tiprankstipranks
Achilles Therapeutics receives approval to transfer to Nasdaq Capital Market
PremiumThe FlyAchilles Therapeutics receives approval to transfer to Nasdaq Capital Market
2M ago
Achilles Therapeutics Explores Strategic Options Amid Financial Update
Premium
Company Announcements
Achilles Therapeutics Explores Strategic Options Amid Financial Update
3M ago
Achilles Therapeutics reports Q3 EPS (48c) vs. (42c) last year
Premium
The Fly
Achilles Therapeutics reports Q3 EPS (48c) vs. (42c) last year
3M ago
Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
PremiumThe FlyAchilles Therapeutics reports Q2 EPS (41c) vs (42c) last year
6M ago
Leadership Shift at Achilles Therapeutics
Premium
Company Announcements
Leadership Shift at Achilles Therapeutics
6M ago
Achilles Therapeutics AGM Concludes with Key Approvals
Premium
Company Announcements
Achilles Therapeutics AGM Concludes with Key Approvals
7M ago
Achilles Therapeutics reports Q1 EPS (30c), consensus (46c)
PremiumThe FlyAchilles Therapeutics reports Q1 EPS (30c), consensus (46c)
9M ago
Piper downgardes Achilles Therapeutics, says ‘step-function’ change needed
Premium
The Fly
Piper downgardes Achilles Therapeutics, says ‘step-function’ change needed
10M ago
Achilles Therapeutics price target lowered to $6 from $11 at Chardan
Premium
The Fly
Achilles Therapeutics price target lowered to $6 from $11 at Chardan
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100